Byeong-Ui Moon

Dr. Byeong-Ui Moon

Research officer

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2016 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
Byeong-Ui MoonByeong-Ui Moon
Byeong-Ui Moon
DHDaekun Hwang
Daekun Hwang
STScott S. H. Tsai
Scott S. H. Tsai
We demonstrate the dynamic control of aqueous two phase system (ATPS) droplets in shrinking, growing, and dissolving conditions. The ATPS droplets are formed passively in a flow focusing microfluidic channel, where the dextran-rich (DEX) and polyethylene glycol-rich (PEG) solutions are introduced as disperse and continuous phases, respectively. To vary the ATPS equilibrium condition, we infuse into a secondary inlet the PEG phase from a different polymer concentration ATPS. We find that the resulting alteration of the continuous PEG phase can cause droplets to shrink or grow by approximately 45 and 30%, respectively. This volume change is due to water exchange between the disperse DEX and continuous PEG phases, as the system tends towards new equilibria. We also develop a simple model, based on the ATPS binodal curve and tie lines, that predicts the amount of droplet shrinkage or growth, based on the change in the continuous phase PEG concentration. We observe a good agreement between our experimental results and the model. Additionally, we find that when the continuous phase PEG concentration is reduced such that PEG and DEX phases no longer phase separate, the ATPS droplets are dissolved into the continuous phase. We apply this method to controllably release encapsulated microparticles and cells, and we find that their release occurs within 10 seconds. Our approach uses the dynamic equilibrium of ATPS to control droplet size along the microfluidic channel. By modulating the ATPS equilibrium, we are able to shrink, grow, and dissolve ATPS droplets in situ. We anticipate that this approach may find utility in many biomedical settings, for example, in drug and cell delivery and release applications.

11 September 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
LMLidija Malic
Lidija Malic
LCLiviu Clime
Liviu Clime
Byeong-Ui MoonByeong-Ui Moon
Byeong-Ui Moon
CNChristina Nassif
Christina Nassif
DFDillon Da Fonte
Dillon Da Fonte
TVTeodor Veres
Teodor Veres
Fully automated sample-to-answer ddPCR for virus quantification is implemented on a centrifugal platform with active pneumatic pumping comprising wireless heaters and miniaturized fluorescence imaging system.

12 November 2020 in Langmuir
Verified
Journal Article
Closed access
Byeong-Ui MoonByeong-Ui Moon
Byeong-Ui Moon
LMLidija Malic
Lidija Malic
KMKeith Morton
Keith Morton
MJMorteza Jeyhani
Morteza Jeyhani
AEAbdelrahman Elmanzalawy
Abdelrahman Elmanzalawy
TVTeodor Veres
Teodor Veres

18 September 2024 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
Byeong-Ui MoonByeong-Ui Moon
Byeong-Ui Moon
KLKebin Li
Kebin Li
LMLidija Malic
Lidija Malic
KMKeith Morton
Keith Morton
HSHan Shao
Han Shao
TVTeodor Veses
Teodor Veses
Transplantable ready-made microvessels have therapeutic potential for tissue regeneration and cell replacement therapy. Inspired by the natural rapid angiogenic sprouting of microvessels in vivo, engineered injectable 3D microvessel networks are created using thermoplastic elastomer (TPE) microfluidic devices. The TPE material used here is flexible, optically transparent, and can be robustly yet reversibly bonded to a variety of plastic substrates, making it a versatile choice for microfluidic device fabrication because it overcomes the weak self-adhesion properties and limited manufacturing options of poly(dimethylsiloxane) (PDMS). By leveraging the reversible bonding characteristics of TPE material templates, we present their utility as an organ-on-a-chip platform for forming and handling microvessel networks, and demonstrate their potential for animal-free tissue generation and transplantation in clinical applications. We first show that TPE-based devices have nearly 6-fold higher bonding strength during the cell culture step compared to PDMS-based devices while simultaneously maintaining a full reversible bond to (PS) culture plates, which are widely used for biological cell studies. We also demonstrate the successful generation of perfusable and interconnected 3D microvessel networks using TPE–PS microfluidic devices on both single and multi-vessel loading platforms. Importantly, after removing the TPE slab, microvessel networks remain intact on the PS substrate without any structural damage and can be effectively harvested following gel digestion. The TPE-based organ-on-a-chip platform offers substantial advantages by facilitating the harvesting procedure and maintaining the integrity of microfluidic-engineered microvessels for transplant. To the best of our knowledge, our TPE-based reversible bonding approach marks the first confirmation of successful retrieval of organ-specific vessel segments from the reversibly-bonded TPE microfluidic platform. We anticipate that the method will find applications in organ-on-a-chip and microphysiological system research, particularly in tissue analysis and vessel engraftment, where flexible and reversible bonding can be utilized.

4 October 2021 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
Byeong-Ui MoonByeong-Ui Moon
Byeong-Ui Moon
LCLiviu Clime
Liviu Clime
DBDaniel Brassard
Daniel Brassard
ABAlex Boutin
Alex Boutin
JDJamal Daoud
Jamal Daoud
TVTeodor Veses
Teodor Veses
Fractionating whole blood and separating its constituent components one from another is an essential step in many clinical applications. Currently blood sample handling and fractionation processes remain a predominantly manual task that require well-trained operators to produce reliable and reproducible results. Herein, we demonstrate an advanced on-chip whole human blood fractionation and cell isolation process combining (i) an aqueous two-phase system (ATPS) to create complex separation layers with (ii) a centrifugal microfluidic platform (PowerBlade) with active pneumatic pumping to control and automate the assay. We use a polyethylene glycol (PEG) and dextran (DEX) mixture as the two-phase density gradient media and our automated centrifugal microfluidic platform to fractionate blood samples. Different densities of precisely tuned PEG–DEX solutions were tested to match each of the cell types typically targeted during blood fractionation applications. By employing specially designed microfluidic devices, we demonstrate the automation of the following steps: loading of a whole blood sample on-chip, layering of the blood on the ATPS solution, blood fractionation, precise radial repositioning of the fractionated layers, and finally extraction of multiple, selected fractionated components. Fractionation of up to six distinct layers is shown: platelet-rich plasma, buffy coat, PEG, DEX with neutrophils, red blood cells (RBCs) and high density gradient media (HDGM). Furthermore, through controlled dispensing of HDGM to the fractionation chamber, we show that each of the fractionated layers can be repositioned radially, on-the-fly, without disturbing the interfaces, allowing precise transfer of target fractions and cell types into external vials via a chip-to-world interface. Cell counting analysis and cell viability studies showed equivalence to traditional, manual methods. An overall cell viability greater than 90% of extracted cells demonstrates that the proposed approach is suitable for cell isolation applications. This proof-of-principle demonstration highlights the utility of the proposed system for automated whole blood fractionation and isolation for blood cell applications. We anticipate that the proposed approach will be a useful tool for many clinical applications such as standard cell isolation procedures and other bioanalytical assays (e.g., circulating tumor cells, and cell and gene therapy).

29 December 2020 in Processes
Verified
Journal Article
Open access
PDF file
Byeong-Ui MoonByeong-Ui Moon
Byeong-Ui Moon
KMKeith James Morton
Keith James Morton
Kebin LiKebin Li
Kebin Li
CMCaroline Miville-Godin
Caroline Miville-Godin
TVTeodor Veses
Teodor Veses
In this paper, we present a simple, versatile method that creates patterns for cell migration studies using thermoplastic elastomer (TPE). The TPE material used here can be robustly, but reversibly, bonded to a variety of plastic substrates, allowing patterning of cultured cells in a microenvironment. We first examine the bonding strength of TPE to glass and polystyrene substrates and com-pare it to thermoset silicone-based PDMS under various conditions and demonstrate that the TPE can be strongly and reversibly bonded on commercially available polystyrene culture plates. In cell migration studies, cell patterns are templated around TPE features cored from a thin TPE film. We show that the significance of fibroblast cell growth with fetal bovine serum (FBS)-cell culture media compared to the cells cultured without FBS, analyzed over two days of cell culture. This simple approach allows us to generate cell patterns without harsh manipulations like scratch assays and to avoid damaging the cells. We also confirm that the TPE material is non-toxic to cell growth and supports a high viability of fibroblasts and breast cancer cells. We anticipate this TPE-based patterning approach can be further utilized for many other cell patterning applications such as in cell-to-cell communication studies.